{
  "actions": [
    {
      "acted_at": "2021-07-09",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2021-07-09",
      "action_code": "H11100",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Ways and Means.",
      "type": "referral"
    },
    {
      "acted_at": "2021-07-09",
      "action_code": "",
      "committees": [
        "HSWM"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Trade.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr4376-117",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Ways and Means",
      "committee_id": "HSWM",
      "subcommittee": "Subcommittee on Trade",
      "subcommittee_id": "04"
    }
  ],
  "congress": "117",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-07-09",
  "number": "4376",
  "official_title": "To identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Use Sovereignty To reduce Rx Act",
  "sponsor": {
    "bioguide_id": "A000375",
    "district": "19",
    "name": "Arrington, Jodey C.",
    "state": "TX",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-07-09",
  "subjects": [
    "Foreign trade and international finance"
  ],
  "subjects_top_term": "Foreign trade and international finance",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2021-07-09",
    "date": "2022-02-10T17:58:23Z",
    "text": "Use Sovereignty To reduce Rx Act or the USTRx Act\n\nThis bill establishes the role of Chief Pharmaceutical Trade Negotiator within the U.S. Trade Representative (USTR) to conduct trade negotiations, enforce trade agreements relating to U.S. pharmaceutical products, and address acts, policies, or practices of high-income countries that adversely impact the market access of U.S. pharmaceutical manufacturers.\n\nThe USTR must annually compile a list of high-income countries based on official statistics of the International Bank for Reconstruction and Development of the World Bank. Based on that list, the negotiator must submit a report describing (1) such countries' actions and impacts relating to the pharmaceutical trade, and (2) the current status of any responsive actions taken by the United States."
  },
  "titles": [
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To identify and take action against international trade practices of high income countries that unfairly exploit innovation by deviating from market-based policies and unfairly exploit United States innovation, and for other purposes.",
      "type": "official"
    },
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "USTRx Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Use Sovereignty To reduce Rx Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "USTRx Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-03-08T19:58:02Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr/BILLSTATUS-117hr4376.xml"
}